PCSCs from mPIN (mouse prostate intraepithelial neoplasia, a precursor lesion to murine PCa) used TNC (Tenascin-C), an ECM disulfide-linked hexameric glycoprotein, as a strategy to overcome immune surveillance [80]. The gene discussed is TNC; the disease is prostate intraepithelial neoplasia.